patent

News

Alvotech files lawsuit challenging AbbVie's Humira patent th...

Biosimilars firm Alvotech has filed a lawsuit that challenges AbbVie’s legal defences surrounding the inflammatory disease drug Humira in the US.

News

Pfizer shares slump as support grows for COVID-19 vaccine pa...

Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a move aimed to boost global supplies of the life-saving shots.

News

Teva faces EU antitrust probe over MS drug Copaxone

The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic versions of its

News

AstraZeneca breathes sigh of relief as court blocks US Symbi...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster.

News

EU fines Teva and Cephalon €60.5m for 'pay for delay' scheme

The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder dru

News

Amgen's cancer biosimilars stay on US market as court battle...

Amgen has scored yet another home run in the US courts, this time seeing off a legal challenge from Genentech, which was trying to block it from launching two cut-price cancer biosimilars.

Alvotech files lawsuit challenging AbbVie's Humira patent th...

Pfizer shares slump as support grows for COVID-19 vaccine pa...

Teva faces EU antitrust probe over MS drug Copaxone

AstraZeneca breathes sigh of relief as court blocks US Symbi...

EU fines Teva and Cephalon €60.5m for 'pay for delay' scheme

Amgen's cancer biosimilars stay on US market as court battle...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

patent

Editor's Picks